Tulane University School of Public Health and Tropical Medicine
New Orleans, Louisiana, 70112, United States
Location status: Recruiting
Location contact
Kirsten Dorans, ScD
CONTACT
Tara Dobson, BA
CONTACT
NCT Number: NCT06116149
The primary objective of the STRIVE study is to compare two implementation strategies for Diabetes Prevention Program delivery: an in-person health coach strategy (standard 24 in-person sessions at WIC clinics) vs. a multifaceted technology-assisted health coach implementation strategy (12 in-person sessions at WIC clinics supplemented by technology support) on implementation and health-related outcomes in postpartum women.
Interested in participating?
Request Info18 year and older
Female
Interventional
Not applicable
New Orleans, Louisiana, 70112, United States
Location status: Recruiting
Kirsten Dorans, ScD
CONTACT
Tara Dobson, BA
CONTACT
The overall objective of this project is to study the implementation, effectiveness, and sustainability of implementing the Diabetes Prevention Program (DPP) in postpartum women who receive services from WIC. In this effectiveness-implementation type III cluster-randomized trial, we will compare two implementation strategies for DPP delivery: an in-person health coach-led implementation strategy (standard 24 in-person sessions) vs. a multifaceted technology-assisted health coach implementation strategy (12 in-person sessions supplemented by technology tools).
Nineteen clinics will be randomized to the multifaceted technology-assisted health coach strategy and 19 to the in-person health coach-led strategy. A total of 722 postpartum participants (19 per clinic) will be recruited into the study and followed for 12 months for implementation and effectiveness outcomes. A post-intervention study visit will take place 6 months after the end of the 12-month intervention to evaluate the sustainability of the implementation strategies.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
for Clinics:
Inclusion criteria
for Participants:
Delivery of 24 health coaching sessions in-person by health coaches over 1 year.
Standard delivery of 24-sessions of the Group Lifestyle Balance (GLB) behavioral intervention in WIC clinics. The GLB was adapted from the original Lifestyle Balance behavioral intervention used in the original Diabetes Prevention Program trial for use in community translation and group settings. It focuses on improving diet and physical activity and promoting moderate weight loss through health coaching on behavioral change, including self-monitoring of food intake, physical activity, and weight.
Delivery of 12 health coaching GLB sessions in-person by health coaches over one year; supplemental technology support, including tools for self-monitoring, health coach monitoring, asynchronous delivery of intervention materials, and asynchronous coach and group connection.
The GLB was adapted from the original Lifestyle Balance behavioral intervention used in the original Diabetes Prevention Program trial for use in community translation and group settings. It focuses on improving diet and physical activity and promoting moderate weight loss through health coaching on behavioral change, including self-monitoring of food intake, physical activity, and weight.
Time frame: Measured from baseline to 12 months
The primary implementation outcome will be the difference between study arms in a composite uptake score, as defined by a composite score consisting of the percent of sessions attended and the percentage of times in which participants record weight, activity, and diet compared to what is recommended by the intervention.
Time frame: Measured at 3, 6, 9 and 12 months
The primary health-related outcome will be difference in mean weight reduction from baseline to 12 months between study arms
Time frame: 12 months
Percentage of sessions held
Time frame: Measured at baseline, 6, and 12 months
Acceptability scores for participants, DPP coordinators, DPP coaches, WIC clinic management. Measured by survey; higher score means better outcome.
Time frame: baseline
Appropriateness scores for participants, DPP coordinators, DPP coaches, WIC clinic management. Measured by survey; higher score means better outcome.
Time frame: Baseline
Feasibility scores for participants, DPP coordinators, DPP coaches, and WIC clinic management. Measured by survey; higher score means better outcome.
Time frame: Baseline
Percentage of invited WIC clinics adopting the DPP program. Measured by study administrative data.
Time frame: Baseline
Percentage of invited WIC nutritionists being trained. Measured by study administrative data.
Time frame: Baseline
Percentage of invited WIC health educators being trained. Measured by study administrative data.
Time frame: 12 months
Percentage of enrolled participants receiving assigned intervention. Measured by study administrative data.
Time frame: 12 months
Percentage of percentage of trained WIC DPP coordinators supporting health coaches. Measured by study administrative data.
Time frame: 12 months
Percentage of percentage of trained WIC DPP health coaches delivering the intervention. Measured by study administrative data.
Time frame: Baseline
Reach
Time frame: 12 months
Incremental direct costs (intervention) per additional percentage of individuals reaching weight loss goal at 12 months
Time frame: Measured from baseline to 12 months
Difference in mean percent weight reduction from baseline to 12 months between study arms
Time frame: Measured from baseline to 12 months
Difference in mean change in physical activity from baseline to 12 months between study arms, as assessed by metabolic equivalent (MET)-h/week (measured by validated questionnaire)
Time frame: Measured from baseline to 12 months
Difference in mean change in healthy eating index from baseline to 12 months between study arms, as assessed by 24-hour dietary recalls (range 0 to 100; higher scores mean healthier eating pattern)
Time frame: Measured from baseline to 12 months
Difference in mean change in waist circumference from baseline to 12 months between study arms
Time frame: Measured from baseline to 12 months
Difference in mean change in hemoglobin A1c from baseline to 12 months between study arms
Time frame: Measured from baseline to 12 months
Difference in mean change in systolic blood pressure from baseline to 12 months between study arms
Time frame: Measured from baseline to 12 months
Difference in mean change in diastolic blood pressure from baseline to 12 months between study arms
Time frame: Measured from baseline to 12 months
Difference in mean change in health-related quality of life (HRQoL) from baseline to 12 months between study arms (assessed by short form (SF)-12, validated survey)
Time frame: Measured from baseline to 12 months
Assessed by validated questionnaires, 24-hour dietary recalls, and weight measurements
Time frame: 18 months
Assessed by surveys and interviews
Time frame: 18 months
Assessed by validated questionnaires, 24-hour dietary recalls, and weight measurements
Contact information is provided by the study sponsor or research team.
Kirsten Dorans, ScD
CONTACT
Tara Dobson, BA
CONTACT
Tulane University
Other
Strategies for Implementing a Postpartum Lifestyle Intervention in WIC Clinics: A Cluster Randomized Trial
Acronym: STRIVE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05056376
Behavior, Body Weight
Baltimore, Maryland, United States
View Trial DetailsNCT01405547
Body Weight, Diabetes Mellitus
Toronto, Ontario, Canada
View Trial DetailsNCT06118931
Behavior, Body Weight
Toronto, Ontario, Canada
View Trial DetailsNCT05144737
Body Weight, Cardiovascular Diseases
Baltimore, Maryland, United States
View Trial Details